Literature DB >> 11026626

Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women.

N R Matthan1, M Raeini-Sarjaz, A H Lichtenstein, L M Ausman, P J Jones.   

Abstract

To assess the validity of two techniques used to measure human cholesterol synthesis, the rate of uptake of deuterium (D) into plasma free cholesterol (FC), and plasma cholesterol precursor (squalene, lanosterol, desmosterol and lathosterol) levels were compared in 14 women [65-71 yr with low density lipoprotein-cholesterol (LDL-C) > or = 3.36 mmol x L(-1)]. Subjects consumed each of six diets for 5-wk periods according to a randomized crossover design. The experimental diets included a baseline diet (39% energy as fat, 164 mg chol x 4.2 MJ(-1)) and five reduced-fat diets (30% of energy as fat), where two-thirds of the fat was either soybean oil; squeeze, tub or stick margarines; or butter. Fractional and absolute synthesis rates (FSR and ASR) of FC were determined using the deuterium incorporation (DI) method, while cholesterol precursor levels were measured using gas-liquid chromatography. Data were pooled across diets for each variable and correlation coefficients were calculated to determine if associations were present. There was good agreement among levels of the various cholesterol precursors. In addition, FSR in pools/d (p x d(-1)) and ASR in grams/d (g x d(-1)) were strongly associated with lathosterol (r= 0.72 and 0.71, P= 0.0001), desmosterol (r= 0.75 and 0.75, P = 0.0001), lanosterol (r = 0.67 and 0.67), and squalene (r = 0.69 and 0.68) when levels of the precursors were expressed as micromol x mmol(-1) C. Significant but lower correlations were observed between the D uptake and plasma cholesterol precursor levels when the latter were expressed in absolute amounts (micromol x L(-1)). The wide range of fatty acid profiles of the experimental diets did not influence the degree of association between methods. In conclusion, the DI method and levels of some cholesterol precursors correspond as methods for shortterm measurement of cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026626     DOI: 10.1007/s11745-000-0616-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  40 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol.

Authors:  W C Duane
Journal:  J Lipid Res       Date:  1995-02       Impact factor: 5.922

3.  Interaction of dietary fat saturation and cholesterol level on cholesterol synthesis measured using deuterium incorporation.

Authors:  P J Jones; A H Lichtenstein; E J Schaefer
Journal:  J Lipid Res       Date:  1994-06       Impact factor: 5.922

4.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

Authors:  A H Lichtenstein; L M Ausman; S M Jalbert; E J Schaefer
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

5.  Plasma cholesterol synthesis using deuterated water in humans: effect of short-term food restriction.

Authors:  P J Jones; A M Scanu; D A Schoeller
Journal:  J Lab Clin Med       Date:  1988-06

6.  Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver.

Authors:  I Björkhem; T Miettinen; E Reihnér; S Ewerth; B Angelin; K Einarsson
Journal:  J Lipid Res       Date:  1987-10       Impact factor: 5.922

7.  Plasma mevalonate as a measure of cholesterol synthesis in man.

Authors:  T S Parker; D J McNamara; C D Brown; R Kolb; E H Ahrens; A W Alberts; J Tobert; J Chen; P J De Schepper
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Three-pool model of the long-term turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

9.  Effect of dietary fat selection on plasma cholesterol synthesis in older, moderately hypercholesterolemic humans.

Authors:  P J Jones; A H Lichtenstein; E J Schaefer; G L Namchuk
Journal:  Arterioscler Thromb       Date:  1994-04

10.  Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.

Authors:  M I Uusitupa; T A Miettinen; P Happonen; T Ebeling; H Turtola; E Voutilainen; K Pyörälä
Journal:  Arterioscler Thromb       Date:  1992-07
View more
  15 in total

1.  Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.

Authors:  Huicui Meng; Nirupa R Matthan; Edith Angellotti; Anastassios G Pittas; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

2.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

3.  Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster.

Authors:  Jaime L Lecker; Nirupa R Matthan; Jeffrey T Billheimer; Daniel J Rader; Alice H Lichtenstein
Journal:  Metabolism       Date:  2010-03-02       Impact factor: 8.694

4.  Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.

Authors:  Valerio Leoni; Laura Strittmatter; Giovanna Zorzi; Federica Zibordi; Sabrina Dusi; Barbara Garavaglia; Paola Venco; Claudio Caccia; Amanda L Souza; Amy Deik; Clary B Clish; Marco Rimoldi; Emilio Ciusani; Enrico Bertini; Nardo Nardocci; Vamsi K Mootha; Valeria Tiranti
Journal:  Mol Genet Metab       Date:  2011-12-14       Impact factor: 4.797

5.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

6.  Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.

Authors:  Nirupa R Matthan; Michael Pencina; Jane M LaRocque; Paul F Jacques; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2009-05-12       Impact factor: 5.922

7.  Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.

Authors:  Gissette Reyes-Soffer; Byoung Moon; Antonio Hernandez-Ono; Marija Dionizovik-Dimanovski; Marija Dionizovick-Dimanovski; Jhonsua Jimenez; Joseph Obunike; Tiffany Thomas; Colleen Ngai; Nelson Fontanez; Daniel S Donovan; Wahida Karmally; Stephen Holleran; Rajasekhar Ramakrishnan; Robert S Mittleman; Henry N Ginsberg
Journal:  Sci Transl Med       Date:  2016-01-27       Impact factor: 17.956

8.  Plasma plant sterols serve as poor markers of cholesterol absorption in man.

Authors:  Lily Jakulj; Hussein Mohammed; Theo H van Dijk; Theo Boer; Scott Turner; Albert K Groen; Maud N Vissers; Erik S G Stroes
Journal:  J Lipid Res       Date:  2012-11-25       Impact factor: 5.922

9.  Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.

Authors:  André J Tremblay; Benoît Lamarche; Jean-Charles Hogue; Patrick Couture
Journal:  J Lipid Res       Date:  2009-03-22       Impact factor: 5.922

10.  Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Authors:  Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.